- 专利标题: STABLE PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
-
申请号: US15527246申请日: 2015-11-06
-
公开(公告)号: US20170340638A1公开(公告)日: 2017-11-30
- 发明人: Mi-Won SOHN , Sun-Woo JANG , Dong-Han WON , Yong-Min KIM , Hyung-Don HWANG , Dong-Hun MIN
- 申请人: DONG-A ST CO., LTD
- 申请人地址: KR Dongdaemun-gu, Seoul
- 专利权人: DONG-A ST CO., LTD
- 当前专利权人: DONG-A ST CO., LTD
- 当前专利权人地址: KR Dongdaemun-gu, Seoul
- 优先权: KR10-2014-0160225 20141117
- 国际申请: PCT/KR2015/011905 WO 20151106
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; A61K9/08 ; A61K31/16 ; A61K31/185
摘要:
Provided is a composition of a ready-to-use injectable solution comprising pemetrexed or pharmaceutically acceptable salts thereof, containing pemetrexed; anhydrous sodium sulfite; and N-acetyl-L-cystein. With respect to use as an injectable preparation. The ready-to-use injectable solution composition is suitable for effective administration of pemetrexed since a melting process of main ingredients is not necessary before administration, and the composition can be used by being diluted immediately in a perfusate. In addition, the properties of the composition do not change even in long-term storage, and pharmaceutical stability is significantly improved by inhibiting related substances below a reference, whereby the composition can be stored in a liquid preparation state.
信息查询
IPC分类: